Trial Profile
A Phase I Trial of Sequential Ipilimumab After Chemoradiation for the Primary Treatment of Patients With Locally Advanced Cervical Cancer Stages IB2/IIA With Positive Para-Aortic Lymph Nodes Only and Stage IIB/IIIB/IVA With Positive Lymph Nodes
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary) ; Cisplatin
- Indications Adenocarcinoma; Carcinoma; Cervical cancer; Squamous cell cancer
- Focus Adverse reactions
- 29 Aug 2020 Status changed from active, no longer recruiting to completed.
- 18 Aug 2020 Results published in the Clinical Cancer Research
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology